Higher drug exposure in women due to lower renal and hepatic clearance and body composition can increase efficacy but also toxicity, highlighting the need to reassess dosing.
The past 30 years have seen tremendous progress in our fundamental understanding of lung cancer and the development of new treatment strategies,” senior researcher Dr. Cary Gross, a professor at Yale ...
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...
EVERY day without a dedicated PhilHealth Z Benefit Package for lung cancer means more Filipino families face delayed ...
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
Post-treatment lung health is a longitudinal survivorship issue; nonregenerative parenchymal loss, radiation fibrosis, and systemic-therapy injury justify ongoing symptom reporting, CT/PFT ...
Dr. Angel Nunez said the technology carries a significantly lower risk than traditional methods.
A new Ohio University study offers a glimmer of hope in the fight against lung cancer. Monica Robins has that story and more ...
A study published this week found that Black Medicare beneficiaries with early-stage NSCLC remain significantly less likely than White beneficiaries to receive curative treatment, largely because of ...
As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...
Recognising these subtle body changes can lead to an earlier diagnosis, when treatment is more likely to be successful ...
Stocktwits on MSN
IBRX founder’s ‘congrats’ to GSK sparks debate after FDA fast drug approvals — retail slams big pharma bias over Anktiva
FDA Commissioner Marty Makary highlighted rapid approvals of the lung cancer drug Zongertinib and the multiple myeloma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results